Strumento inattivo

Azioni Cadence Pharmaceuticals, Inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	28/02/14
Cadence Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.	12/02/14
Cadence Pharmaceuticals, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders	11/02/14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance	13/01/14

Dirigenti	Titolo	Età	Da
Bryan Reasons PSD	President	56	-
Diane K. Sheehan HRO	Human Resources Officer	54	01/05/06

Amministratori	Titolo	Età	Da
Bryan Reasons PSD	President	56	-
Marvin R. Haselhorst BRD	Director/Board Member	-	19/03/14

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-4,24%	86,85 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+2,76%	40,16 Mrd
BIOGEN INC.	-16,49%	31,28 Mrd
UCB	+57,86%	25,27 Mrd
BIOMARIN PHARMACEUTICAL INC.	-15,11%	15,33 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,12%	11,96 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42,56%	11,61 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+6,89%	8,83 Mrd
INNOVENT BIOLOGICS, INC.	-10,53%	7,94 Mrd